Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Amortization of Deferred Charges (2019 - 2025)

Historic Amortization of Deferred Charges for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $14000.0.

  • Pulmonx's Amortization of Deferred Charges rose 2727.27% to $14000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $49000.0, marking a year-over-year decrease of 925.93%. This contributed to the annual value of $52000.0 for FY2024, which is 833.33% up from last year.
  • Per Pulmonx's latest filing, its Amortization of Deferred Charges stood at $14000.0 for Q3 2025, which was up 2727.27% from $13000.0 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Amortization of Deferred Charges ranged from a high of $39000.0 in Q1 2021 and a low of $10000.0 during Q4 2022
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $14000.0 (2022), whereas its average is $15789.5.
  • Per our database at Business Quant, Pulmonx's Amortization of Deferred Charges tumbled by 9484.54% in 2021 and then soared by 6000.0% in 2024.
  • Quarter analysis of 5 years shows Pulmonx's Amortization of Deferred Charges stood at $17000.0 in 2021, then plummeted by 41.18% to $10000.0 in 2022, then increased by 30.0% to $13000.0 in 2023, then dropped by 15.38% to $11000.0 in 2024, then rose by 27.27% to $14000.0 in 2025.
  • Its last three reported values are $14000.0 in Q3 2025, $13000.0 for Q2 2025, and $11000.0 during Q1 2025.